Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: Interim results of a prospective cohort study

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Mikhitarian, Kaidi ^a,c   Martin, Renee Hebert ^b   Ruppel, Megan Baker ^a   Gillanders, William E ^a,d   Hoda, Rana ^a   Schutte, Del H ^a   Callahan, Kathi ^a   Mitas, Michael ^a   Cole, David J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; ESTROGEN RECEPTOR; HEMATOXYLIN; MAMMAGLOBIN; MESSENGER RNA; TUMOR PROTEIN; UTEROGLOBIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BLOOD ANALYSIS; BLOOD SAMPLING; BONE MARROW CELL; BREAST CANCER; CANCER CELL; CANCER GRADING; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE OVEREXPRESSION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; BLOOD; BREAST TUMOR; FEMALE; GENETICS; LYMPH NODE; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW CELLS; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RNA, MESSENGER; UTEROGLOBIN;

EID: 42249100865     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-55     Document Type: Article

References (45)

1. Braun S Vogl FD Naume B Janni W Osborne MP Coombes RC Schlimok G Diel IJ Gerber B Gebauer G Pierga JY Marth C Oruzio D Wiedswang G Solomayer EF Kundt G Strobl B Fehm T Wong GY Bliss J Vincent-Salomon A Pantel K A pooled analysis of bone marrow micrometastasis in breast cancer The New England journal of medicine 2005, 353(8):793-802. 10.1056/NEJMoa050434 16120859
2. Yu JJ Brennan M Christos P Osborne MP Hoda S Simmons RM Bone marrow micrometastases and adjuvant treatment of breast cancer The breast journal 2004, 10(3):181-185. 10.1111/j.1075-122X.2004.21292.x 15125741
3. Trocciola SM Hoda S Osborne MP Christos PJ Levin H Martins D Carson J Daly J Simmons RM Do bone marrow micrometastases correlate with sentinel lymph node metastases in breast cancer patients? Journal of the American College of Surgeons 2005, 200(5):720-5; discussion 725-6 10.1016/ j.jamcollsurg.2004.12.029 15848362
4. Slade MJ Singh A Smith BM Tripuraneni G Hall E Peckitt C Fox S Graham H Luchtenborg M Sinnett HD Cross NC Coombes RC Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: Results at 4 years International journal of cancer 2005, 114(1):94-100. 10.1002/ijc.20655 15523696
5. Pierga JY Bonneton C Vincent-Salomon A de Cremoux P Nos C Blin N Pouillart P Thiery JP Magdelenat H Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients Clin Cancer Res 2004, 10(4):1392-1400. 10.1158/1078-0432.CCR-0102-03 14977842
6. Benoy IH Elst H Van der Auwera I Van Laere S van Dam P Van Marck E Scharpe S Vermeulen PB Dirix LY Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer British journal of cancer 2004, 91(10):1813-1820. 10.1038/sj.bjc.6602189 15505629
7. Becker S Becker-Pergola G Fehm T Wallwiener D Solomayer EF Her2 expression on disseminated tumor cells from bone marrow of breast cancer patients Anticancer research 2005, 25(3B):2171-2175. 16158960
8. Muller V Stahmann N Riethdorf S Rau T Zabel T Goetz A Janicke F Pantel K Circulating tumor cells in breast cancer: Correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity Clin Cancer Res 2005, 11(10):3678-3685. 10.1158/ 1078-0432.CCR-04-2469 15897564
9. Bauernhofer T Zenahlik S Hofmann G Balic M Resel M Pirchmoser R Regitnig P Ambros P Dandachi N Samonigg H Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer Oncology reports 2005, 13(2):179-184. 15643496
10. Taubert H Blumke K Bilkenroth U Meye A Kutz A Bartel F Lautenschlager C Ulbrich EJ Nass N Holzhausen HJ Koelbl H Lebrecht A Detection of disseminated tumor cells in peripheral blood of patients with breast cancer: Correlation to nodal status and occurrence of metastases Gynecologic oncology 2004, 92(1):256-261. 10.1016/j.ygyno.2003.09.009 14751168
11. Gaforio JJ Serrano MJ Sanchez-Rovira P Sirvent A Delgado-Rodriguez M Campos M de la Torre N Algarra I Duenas R Lozano A Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis International journal of cancer 2003, 107(6):984-990. 10.1002/ijc.11479 14601059
12. Janku F Kleibl Z Novotny J Tesarova P Petruzelka L Matous B Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer Neoplasma 2004, 51(3):204-208. 15254674
13. Benoy IH Elst H Philips M Wuyts H Van Dam P Scharpe S Van Marck E Vermeulen PB Dirix LY Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer British journal of cancer 2006, 94(5):672-680. 16495933
14. Ooka M Tamaki Y Sakita I Fujiwara Y Yamamoto H Miyake Y Sekimoto M Ohue M Sugita Y Miyoshi Y Ikeda N Noguchi S Monden M Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer Breast cancer research and treatment 2001, 67(2):169-175. 10.1023/A:1010651632354 11519865
15. Bozionellou V Mavroudis D Perraki M Papadopoulos S Apostolaki S Stathopoulos E Stathopoulou A Lianidou E Georgoulias V Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer Clin Cancer Res 2004, 10(24):8185-8194. 10.1158/1078-0432.CCR-03-0094 15623593
16. Masuda TA Kataoka A Ohno S Murakami S Mimori K Utsunomiya T Inoue H Tsutsui S Kinoshita J Masuda N Moriyama N Mori M Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients International journal of oncology 2005, 26(3):721-730. 15703829
17. Pierga JY Bonneton C Magdelenat H Vincent-Salomon A Nos C Boudou E Pouillart P Thiery JP de Cremoux P Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients International journal of cancer 2005, 114(2):291-298. 10.1002/ijc.20698 15543615
18. Benoy IH Salgado R Elst H Van Dam P Weyler J Van Marck E Scharpe S Vermeulen PB Dirix LY Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer Breast Cancer Res 2005, 7(2):R210-9. 1064134 15743502 10.1186/bcr980
19. Ismail MS Wynendaele W Aerts JL Paridaens R Gaafar R Shakankiry N Khaled HM Christiaens MR Wildiers H Omar S Vandekerckhove P Van Oosterom AT Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCR Clin Cancer Res 2004, 10(1 Pt 1):196-201. 10.1158/1078-0432.CCR-0515-2 14734470
20. Roncella S Ferro P Bacigalupo B Pronzato P Tognoni A Falco E Gianquinto D Ansaldo V Dessanti P Fais F Rosai J Fedeli F Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood J Exp Clin Cancer Res 2005, 24(2):265-271. 16110760
21. Mercatali L Valenti V Calistri D Calpona S Rosti G Folli S Gaudio M Frassineti GL Amadori D Flamini E RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patients Ann Oncol 2006, 17(3):424-428. 10.1093/annonc/mdj109 16357022
22. Giatromanolaki A Koukourakis MI Kakolyris S Mavroudis D Kouroussis C Mavroudi C Perraki M Sivridis E Georgoulias V Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse International journal of cancer 2004, 108(4):620-627. 10.1002/ijc.11593 14696130
23. Stathopoulos EN Sanidas E Kafousi M Mavroudis D Askoxylakis J Bozionelou V Perraki M Tsiftsis D Georgoulias V Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes Ann Oncol 2005, 16(2):240-246. 10.1093/annonc/mdi043 15668277
24. Cerveira N Torres L Rocha P Bizarro S Pereira D Abreu J Henrique R Teixeira MR Castedo S Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients International journal of cancer 2004, 108(4):592-595. 10.1002/ijc.11609 14696125
25. Weigelt B Bosma AJ Hart AA Rodenhuis S van't Veer LJ Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients British journal of cancer 2003, 88(7):1091-1094. 10.1038/ sj.bjc.6600868 12671691
26. Fabisiewicz A Kulik J Kober P Brewczynska E Pienkowski T Siedlecki JA Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay Acta biochimica Polonica 2004, 51(3):747-755. 15448736
27. Baker MK Mikhitarian K Osta W Callahan K Hoda R Brescia F Kneuper-Hall R Mitas M Cole DJ Gillanders WE Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology Clin Cancer Res 2003, 9(13):4865-4871. 14581359
28. Zehentner BK Persing DH Deme A Toure P Hawes SE Brooks L Feng Q Hayes DC Critichlow CW Houghton RL Kiviat NB Mammaglobin as a novel breast cancer biomarker: Multigene reverse transcription-PCR assay and sandwich ELISA Clinical chemistry 2004, 50(11):2069-2076. 1482781 15375015 10.1373/ clinchem.2004.038687
29. Ring AE Zabaglo L Ormerod MG Smith IE Dowsett M Detection of circulating epithelial cells in the blood of patients with breast cancer: Comparison of three techniques British journal of cancer 2005, 92(5):906-912. 10.1038/sj.bjc.6602418 15714202
30. Cristofanilli M Budd GT Ellis MJ Stopeck A Matera J Miller MC Reuben JM Doyle GV Allard WJ Terstappen LW Hayes DF Circulating tumor cells, disease progression, and survival in metastatic breast cancer The New England journal of medicine 2004, 351(8):781-791. 10.1056/NEJMoa040766 15317891
31. Mitas M Mikhitarian K Walters C Baron PL Elliott BM Brothers TE Robison JG Metcalf JS Palesch YY Zhang Z Gillanders WE Cole DJ Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel International journal of cancer 2001, 93(2):162-171. 10.1002/ijc.1312 11410861
32. Mitas M Hoover L Silvestri G Reed C Green M Turrisi AT Sherman C Mikhitarian K Cole DJ Block MI Gillanders WE Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected] J Mol Diagn 2003, 5(4):237-242. 1907342 14573783
33. Gillanders WE Mikhitarian K Hebert R Mauldin PD Palesch Y Walters C Urist MM Mann GB Doherty G Herrmann VM Hill AD Eremin O El-Sheemy M Orr RK Valle AA Henderson MA Dewitty RL Sugg SL Frykberg E Yeh K Bell RM Metcalf JS Elliott BM Brothers T Robison J Mitas M Cole DJ Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: An interim analysis of a prospective multi-institutional cohort study Annals of surgery 2004, 239(6):828-37; discussion 837-40 1356291 15166962 10.1097/01.sla.0000128687.59439.d6
34. Mikhitarian K Martin RH Mitas M Mauldin PD Palesch Y Metcalf JS Cole DJ Gillanders WE Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: Results of a multi-institutional prospective cohort study Surgery 2005, 138(3):474-481. 10.1016/j.surg.2005.07.001 16213901
35. Mitas M Almeida JS Mikhitarian K Gillanders WE Lewin DN Spyropoulos DD Hoover L Graham A Glenn T King P Cole DJ Hawes R Reed CE Hoffman BJ Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR Clin Cancer Res 2005, 11(6):2205-2214. 10.1158/1078-0432.CCR-04-1091 15788668
36. Mitas M Mikhitarian K Hoover L Lockett MA Kelley L Hill A Gillanders WE Cole DJ Prostate-Specific Ets (PSE) factor: A novel marker for detection of metastatic breast cancer in axillary lymph nodes British journal of cancer 2002, 86(6):899-904. 10.1038/sj.bjc.6600190 11953821
37. Osta WA Chen Y Mikhitarian K Mitas M Salem M Hannun YA Cole DJ Gillanders WE EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy Cancer research 2004, 64(16):5818-5824. 10.1158/0008-5472.CAN-04-0754 15313925
38. Hsu SM Raine L Fanger H Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures J Histochem Cytochem 1981, 29(4):577-580. 6166661
39. Goldhirsch A Glick JH Gelber RD Coates AS Senn HJ Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer J Clin Oncol 2001, 19(18):3817-3827. 11559719
40. Ruud P Fodstad O Hovig E Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells International journal of cancer 1999, 80(1):119-125. 10.1002/ (SICI)1097-0215(19990105)80:1<119::AID-IJC22>3.0.CO;2-X 9935241
41. Zach O Kasparu H Krieger O Hehenwarter W Girschikofsky M Lutz D Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA J Clin Oncol 1999, 17(7):2015-2019. 10561252
42. Grunewald K Haun M Urbanek M Fiegl M Muller-Holzner E Gunsilius E Dunser M Marth C Gastl G Mammaglobin gene expression: A superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19 Laboratory investigation; a journal of technical methods and pathology 2000, 80(7):1071-1077. 10908152
43. Lin YC Chen SC Hsueh S Lo YF Chow-Wu YH Liaw IC Cheng AJ Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patients Cancer science 2003, 94(1):99-102. 10.1111/j.1349-7006.2003.tb01359.x 12708482
44. Zach O Kasparu H Wagner H Krieger O Lutz D Mammaglobin as a marker for the detection of tumor cells in the peripheral blood of breast cancer patients Annals of the New York Academy of Sciences 2000, 923:343-345. 11193775
45. Stathopoulou A Vlachonikolis I Mavroudis D Perraki M Kouroussis C Apostolaki S Malamos N Kakolyris S Kotsakis A Xenidis N Reppa D Georgoulias V Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: Evaluation of their prognostic significance J Clin Oncol 2002, 20(16):3404-3412. 10.1200/JCO.2002.08.135 12177100